Latest Reports
Global Schizophrenia Epidemiology Analysis and Forecast, 2026
The schizophrenia epidemiology landscape reflects a persistent global mental health burden that continues affecting healthcare systems despite advances in diagnosis and treatment access. Schizophrenia remains a chronic psychiatric disorder ...
Global Charcot–Marie–Tooth Disease Treatment Market - Strategic Insights and Forecasts (2026-2031)
The Charcot–Marie–Tooth (CMT) disease treatment landscape is undergoing gradual transformation because advances in genetic diagnostics are improving identification of disease-causing mutations and enabling more targeted therapeutic developm...
Global Cluster Headache Epidemiology Analysis and Forecast, 2026
Cluster headache remains a rare neurological disorder, yet its clinical burden is disproportionately high because attacks are severe, recurrent, and often resistant to conventional therapies. The epidemiology landscape is changing as awaren...
Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market - Strategic Insights and Forecasts (2026-2035)
The Global Attention Deficit Hyperactivity Disorder (ADHD) treatment landscape covers pharmacological therapies, digital therapeutics, emerging modalities, treatment delivery settings, and commercialization strategies across major geographi...
Global Attention Deficit Hyperactivity Disorder (ADHD) Emerging Therapies Report, 2026 (Q2 Update)
The ADHD emerging therapies landscape focuses on improving symptom control, extending treatment duration, reducing abuse potential, and expanding options for adults and patients who do not respond to conventional stimulants. The market stru...
Global Depression Market - Strategic Insights and Forecasts (2026-2035)
The global depression market is expected to witness substantial growth during the forecast period, driven by rising disease prevalence, increasing awareness of mental health disorders, expanding access to treatment, and continuous innovatio...
Global Autism Spectrum Disorder Treatment Market - Strategic Insights and Forecasts (2026-2035)
Emerging therapies for Autism Spectrum Disorder (ASD) are increasingly focusing on biologically targeted interventions because currently available pharmacological treatments primarily address associated behavioral symptoms rather than core ...
Global Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2026
Autism Spectrum Disorder (ASD) represents one of the fastest-evolving neurodevelopmental epidemiology domains because diagnostic awareness, screening coverage, and healthcare system capacity are changing how affected individuals are identif...
Global Neuromyelitis Optica Treatment Market - Strategic Insights and Forecasts (2026-2035)
The global neuromyelitis optica treatment landscape centers on targeted immunotherapies that suppress relapse activity and prevent irreversible neurological disability. The market structure increasingly depends on biologics directed against...
Global Neuromyelitis Optica Market - Strategic Insights and Forecasts (2026-2035)
The global neuromyelitis optica (NMO) market centers on targeted immunotherapies that reduce relapse frequency and prevent irreversible neurological disability. Demand is shifting from broad immunosuppressive regimens toward biologics with ...
Global Neuromyelitis Optica Epidemiology Analysis and Forecast, 2026
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune neurological disease in which pathogenic antibodies target astrocytes and trigger recurrent inflammatory attacks affecting the optic nerves and spinal cord. The market stru...
Stroke Epidemiology Analysis and Forecast, 2026-2035
Stroke remains one of the leading causes of mortality and long-term neurological disability because aging populations, hypertension prevalence, and metabolic disorders continue increasing simultaneously across global healthcare systems. Isc...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.